NZ234593A - Process for controlling the bioavailability of an oral medicine by using total milk protein extracts - Google Patents
Process for controlling the bioavailability of an oral medicine by using total milk protein extractsInfo
- Publication number
- NZ234593A NZ234593A NZ234593A NZ23459390A NZ234593A NZ 234593 A NZ234593 A NZ 234593A NZ 234593 A NZ234593 A NZ 234593A NZ 23459390 A NZ23459390 A NZ 23459390A NZ 234593 A NZ234593 A NZ 234593A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical composition
- composition according
- oxodipine
- milk protein
- protein extracts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8910605A FR2650502B1 (fr) | 1989-08-07 | 1989-08-07 | Nouvelle forme galenique orale ameliorant la biodisponibilite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ234593A true NZ234593A (en) | 1993-04-28 |
Family
ID=9384532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ234593A NZ234593A (en) | 1989-08-07 | 1990-07-20 | Process for controlling the bioavailability of an oral medicine by using total milk protein extracts |
Country Status (25)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128244C (en) * | 1992-01-17 | 1998-09-22 | Jens-Christian Wunderlich | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
| DE4221880A1 (de) * | 1992-07-03 | 1994-01-05 | Alfatec Pharma Gmbh | Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen |
| KR20030089147A (ko) * | 2002-05-16 | 2003-11-21 | 슈라펫 주식회사 | 애완동물용 급수통 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE854414C (de) * | 1949-04-26 | 1952-11-04 | Dieter Dr Med Ellenbeck | Verfahren zur Herstellung von injizierbaren Loesungen von an sich mehr oder weniger schwer loeslichen Arzneimitteln |
| GB715874A (en) * | 1952-10-03 | 1954-09-22 | Horlicks Ltd | A tablet for use in treating peptic ulcers |
| GB906422A (en) * | 1958-05-02 | 1962-09-19 | Wellcome Found | Improvements in and relating to prolonged acting pharmaceutical preparations |
| US3015611A (en) * | 1959-08-25 | 1962-01-02 | Nysco Lab Inc | Low density whey-bound tablets |
| GB1063872A (en) * | 1962-08-11 | 1967-03-30 | Wellcome Found | Improvements in and relating to prolonged acting pharmaceutical compositions |
| US3594467A (en) * | 1968-10-09 | 1971-07-20 | Richardson Merrell Inc | Long-lasting troche |
| US3922379A (en) * | 1973-12-17 | 1975-11-25 | Abbott Lab | Microencapsulation process |
| US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| DE3200766A1 (de) * | 1981-01-14 | 1982-09-16 | Toyo Jozo Kk | Praeparat mit ausgezeichneter absorptionseigenschaft |
| FR2524312B1 (fr) * | 1982-04-01 | 1985-10-04 | Tech Cuir Centre | Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif |
| JPS59101423A (ja) * | 1982-12-02 | 1984-06-12 | Takada Seiyaku Kk | 新規なニフエジピン固形製剤 |
| CA1249968A (en) * | 1984-04-05 | 1989-02-14 | Kazuo Kigasawa | Ointment base |
| US4670251A (en) * | 1984-05-30 | 1987-06-02 | Igene Biotechnology, Inc. | Microcrystalline tableting excipient derived from whey |
| NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
| IL78017A (en) * | 1986-03-03 | 1989-06-30 | Yissum Res Dev Co | Sustained release tablets of theophylline |
| DE3702105A1 (de) * | 1987-01-24 | 1988-08-04 | Bayer Ag | Parenterale loesung |
| US5051406A (en) * | 1987-03-04 | 1991-09-24 | Nippon Hypox Laboratories Incorporated | Pharmaceutical composition using albumin as a carrier and process for producing the same |
| CA1324083C (en) * | 1987-03-09 | 1993-11-09 | Tetsu Miyoshi | Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
| DK179687D0 (da) * | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
| DE3881615T2 (de) * | 1987-09-08 | 1993-09-23 | Takeda Chemical Industries Ltd | Wasserunloesliche cytokine. |
-
1989
- 1989-08-07 FR FR8910605A patent/FR2650502B1/fr not_active Expired - Fee Related
-
1990
- 1990-07-17 IL IL95105A patent/IL95105A0/xx unknown
- 1990-07-18 IE IE262990A patent/IE902629A1/en unknown
- 1990-07-19 IN IN578/MAS/90A patent/IN170789B/en unknown
- 1990-07-20 DE DE4023136A patent/DE4023136A1/de not_active Withdrawn
- 1990-07-20 NZ NZ234593A patent/NZ234593A/en unknown
- 1990-07-26 ZA ZA905886A patent/ZA905886B/xx unknown
- 1990-07-26 PT PT94823A patent/PT94823A/pt not_active Application Discontinuation
- 1990-08-01 LU LU87777A patent/LU87777A1/fr unknown
- 1990-08-01 EP EP90402199A patent/EP0412877A1/fr not_active Withdrawn
- 1990-08-01 CA CA002022447A patent/CA2022447A1/fr not_active Abandoned
- 1990-08-02 MA MA22193A patent/MA21923A1/fr unknown
- 1990-08-03 PE PE1990173269A patent/PE491A1/es unknown
- 1990-08-03 GB GB9017144A patent/GB2234898A/en not_active Withdrawn
- 1990-08-03 CS CS903838A patent/CS276556B6/cs unknown
- 1990-08-04 KR KR1019900011979A patent/KR910004181A/ko not_active Withdrawn
- 1990-08-06 FI FI903885A patent/FI903885A7/fi not_active Application Discontinuation
- 1990-08-06 OA OA59830A patent/OA09301A/xx unknown
- 1990-08-06 CN CN90106874A patent/CN1049455A/zh active Pending
- 1990-08-06 NO NO90903442A patent/NO903442L/no unknown
- 1990-08-06 DD DD90343250A patent/DD297332A5/de not_active IP Right Cessation
- 1990-08-06 HU HU904909A patent/HU204997B/hu not_active IP Right Cessation
- 1990-08-06 AU AU60239/90A patent/AU631235B2/en not_active Ceased
- 1990-08-06 JP JP2209061A patent/JPH0377819A/ja active Pending
- 1990-08-07 TN TNTNSN90111A patent/TNSN90111A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN90111A1 (fr) | 1991-03-05 |
| CS383890A3 (en) | 1992-06-17 |
| IN170789B (enrdf_load_stackoverflow) | 1992-05-23 |
| AU631235B2 (en) | 1992-11-19 |
| IL95105A0 (en) | 1991-06-10 |
| FI903885A0 (fi) | 1990-08-06 |
| NO903442L (no) | 1991-02-08 |
| AU6023990A (en) | 1991-02-07 |
| FI903885A7 (fi) | 1991-02-08 |
| KR910004181A (ko) | 1991-03-28 |
| ZA905886B (en) | 1991-04-24 |
| GB9017144D0 (en) | 1990-09-19 |
| FR2650502A1 (fr) | 1991-02-08 |
| NO903442D0 (no) | 1990-08-06 |
| CA2022447A1 (fr) | 1991-02-08 |
| GB2234898A (en) | 1991-02-20 |
| EP0412877A1 (fr) | 1991-02-13 |
| CN1049455A (zh) | 1991-02-27 |
| FR2650502B1 (fr) | 1994-05-27 |
| OA09301A (fr) | 1992-09-15 |
| DE4023136A1 (de) | 1991-02-14 |
| DD297332A5 (de) | 1992-01-09 |
| MA21923A1 (fr) | 1991-04-01 |
| LU87777A1 (fr) | 1990-12-11 |
| CS276556B6 (en) | 1992-06-17 |
| PT94823A (pt) | 1991-04-18 |
| IE902629A1 (en) | 1991-02-27 |
| PE491A1 (es) | 1991-01-26 |
| HUT55230A (en) | 1991-05-28 |
| HU904909D0 (en) | 1991-01-28 |
| JPH0377819A (ja) | 1991-04-03 |
| HU204997B (en) | 1992-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010213594B2 (en) | Delayed release, oral dosage compositions that contain amorphous CDDO-Me | |
| DE69903404T2 (de) | Celecoxib-Zusammensetzungen | |
| AU686656B2 (en) | Compositions containing piperine | |
| JP4021507B2 (ja) | プロリン含有医薬組成物 | |
| US4933186A (en) | Dihydropyridine depot formulation | |
| JPS63104921A (ja) | 経口投与用調合剤 | |
| JP2588686B2 (ja) | 高脂血症及び動脈硬化症の予防・治療薬 | |
| NZ201008A (en) | Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient | |
| JP2002187848A (ja) | 茶のポリフェノール画分、その使用、及びそれを含有する処方物 | |
| CN104582700B (zh) | 生育三烯酚的经粘膜递送 | |
| EP1707192B1 (en) | Pharmaceutical composition | |
| WO2012090194A2 (en) | Compositions and methods for treating a skin disorder | |
| JPH01313427A (ja) | ジヒドロピリジン類を含有する徐放性製剤 | |
| WO2006056129A1 (fr) | Compositions d'alcaloides d'huperzia serrata comportant de l'huperzine a et de l'huperzine b et preparation de ces compositions | |
| EP0629400A1 (en) | Idebenone compositions for treating Alzheimer's disease | |
| JPH07330584A (ja) | 疲労改善剤 | |
| US6017946A (en) | Serotonin containing formulation for oral administration and method of use | |
| JP2007502331A (ja) | （−）−ヒドロキシクエン酸を安定して制御送達するための方法および組成物 | |
| NZ234593A (en) | Process for controlling the bioavailability of an oral medicine by using total milk protein extracts | |
| DE69816124T2 (de) | Pharmazeutische zusammensetzungen enthaltend zafirlukast | |
| JPH07330593A (ja) | 疲労改善剤 | |
| KR20210110450A (ko) | iLet(innovative Low excipient tablet) 기술을 이용한 정제사이즈 축소를 통해 복용편의성이 증가된 종합비타민제 조성물 및 그 제조방법 | |
| RU2336076C2 (ru) | Пероральное лекарственное средство для восполнения дефицита магния в организме | |
| JPH11504907A (ja) | ジヒドロピリジン、アセチルサリチル酸ニトロエステル及びビタミンを含有する血管性効果を有する組み合わせ調剤 | |
| MXPA06008191A (es) | Composiciones novedosas que comprenden alcoholes primarios superiores y acido nicotinico, y procedimiento de preparacion de las mismas. |